Problematic WHO Reclassification of Myelodysplastic Syndromes
- 19 October 2000
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (19) , 3447-3452
- https://doi.org/10.1200/jco.2000.18.19.3447
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Problems in the classification of CMML—dysplastic versus proliferative typeLeukemia Research, 1998
- Efficacy of erythropoietin in the myelodysplastic syndromes: a meta‐analysis of 205 patients from 17 studiesBritish Journal of Haematology, 1995
- The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia GroupBritish Journal of Haematology, 1994
- Point of View: Chronic Myelomonocytic Leukaemia (CMML)–A Myelodysplastic or Myeloproliferative Syndrome?Leukemia & Lymphoma, 1993
- Treatment of Myelodysplastic Syndromes with AML-Type ChemotherapyLeukemia & Lymphoma, 1993
- Chronic myelomonocytic leukemia: Single entity or heterogeneous disorder?: A prospective multicenter study of 100 patientsCancer Genetics and Cytogenetics, 1991
- The 5q− anomalyCancer Genetics and Cytogenetics, 1985
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- Distinct haematological disorder with deletion of long arm of No. 5 chromosomeNature, 1974